Is the Weight-Loss Drug Revolution Causing a Frailty Epidemic?

1. 1. GLP-1 weight-loss drugs cause rapid, significant lean muscle mass loss, potentially up to 10%, leading to frailty and other health concerns.
2. 2. The muscle loss associated with GLP-1 drugs heightens injury risk, especially for older individuals, with doctors often not providing guidance on resistance training.
3. 3. Experts caution against using GLP-1s as a 'quick fix' and urge more clinical trials to study muscle loss across diverse demographics.
4. 4. A patient named Chanel Robinson achieved significant weight loss with Mounjaro but is now discovering the 'hidden costs' of her treatment.